English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Development and validation of an HPLC-DAD method for bis(12)-hupyridone and its application to a pharmacokinetic study Journal article
Yu H., Li W.M., Cheung M.C., Zuo Z., Carlier P.R., Gu Z.M., Chan K., Huang M., Wang Y.T., Han Y.F.. Development and validation of an HPLC-DAD method for bis(12)-hupyridone and its application to a pharmacokinetic study[J]. Journal of Pharmaceutical and Biomedical Analysis, 2009, 49(2), 410.
Authors:  Yu H.;  Li W.M.;  Cheung M.C.;  Zuo Z.;  Carlier P.R.; et al.
Favorite | TC[WOS]:1 TC[Scopus]:2  IF:3.1/3.1 | Submit date：2018/10/31
Alzheimer's Disease  Bis(12)-hupyridone  Hplc-dad  Pharmacokinetics  
The physicochemical properties and the in vivo AChE inhibition of two potential anti-Alzheimer agents, bis(12)-hupyridone and bis(7)-tacrine Journal article
Yu H., Li W.-M., Kan K.K.W., Ho J.M.K., Carlier P.R., Pang Y.-P., Gu Z.-M., Zhong Z., Chan K., Wang Y.-T., Han Y.-F.. The physicochemical properties and the in vivo AChE inhibition of two potential anti-Alzheimer agents, bis(12)-hupyridone and bis(7)-tacrine[J]. Journal of Pharmaceutical and Biomedical Analysis, 2008, 46(1), 75.
Authors:  Yu H.;  Li W.-M.;  Kan K.K.W.;  Ho J.M.K.;  Carlier P.R.; et al.
Favorite | TC[WOS]:34 TC[Scopus]:43 | Submit date：2018/10/30
Ache Inhibition  Bis(12)-hupyridone  Bis(7)-tacrine  Dimer  Ionization Constant  Lipophilicity  Solubility